Fig. 4From: Simultaneous determination of itraconazole and its CYP3A4-mediated metabolites including N-desalkyl itraconazole in human plasma using liquid chromatography-tandem mass spectrometry and its clinical applicationThe distributions of plasma concentrations of (a) itraconazole, (b) hydroxy itraconazole, (c) keto itraconazole, and (d) N-desalkyl itraconazole in patients receiving 200 mg itraconazole dailyBack to article page